The overall goal of this project is to develop an in-situ polymerizable, biodegradable material for use in cardiovascular applications that minimizes non-specific cell adhesion and contains functional moieties for the attachment of peptides to induce specific cell attachment. A novel block copolymer has been developed incorporating poly(propylene fumarate) (PPF) and poly(ethylene glycol) which satisfies these criteria. PPF is a new biodegradable polymer currently being investigated for orthopedic and cardiovascular applications while PEG is a hydrophilic polymer that has been extensively studied for biomedical applications. The copolymer is chemically crosslinked with PEG diacrylate using an ammonium persulfate-ascorbic acid redox initiator system to form the hydrogel. The PEG and PPF block lengths can be varied to modulate the properties of the hydrogel formed. In this study, the following three parameters were studied, (1) PPF block length, (2) PEG block length, and (3) initial water content, were varied to examine their effects on swelling, degradation and elastic modulus. A factorial experimental design was implemented to assess which of these three parameters had the greatest impact on swelling, degradation and elastic modulus. Swelling was found to be most affected by the initial water content followed by PEG block length and PPF block length. The swelling of the hydrogels ranged from 48% water uptake with low initial water content to up to 77% water uptake with the high initial water content. After three weeks, degradation of the hydrogels ranged from 4-13% mass fraction lost. Elastic modulus was determined by tensile testing of the various hydrogel formulations and ranged from 0.4 to 7.7 MPa.